Dangerous Medical Drugs

March 29, 2018

Recent Drug Recalls

Kratom Powder from PDX Aromatics Kratom is a plant and sold as a stimulant dietary supplement for the treatment of opioid withdrawal symptoms. PDX Aromatics issued a recall for their Kratom powder because of potential Salmonella contamination. Since October of 2017, 87 people across the United States have contracted Salmonella connected to the powder. Limbrel [...]
December 3, 2015

Use May Increase Risk of Birth Defects

If you are in the first trimester of pregnancy and have been prescribed the drug to treat nausea and vomiting, your baby could be at risk for serious birth defects. This is because has not been approved for use in pregnant women. has only been approved by the FDA to treat nausea and vomiting in [...]
June 9, 2015

Antidepressants Linked to Serious Birth Defects

Antidepressants Linked to Serious Birth Defectsby Brayton Purcell LLP | Jun 9, 2015 | Dangerous Medical Drugs | It is reported that over 80,000 pregnant women in the United States are prescribed selective serotonin reuptake inhibitors (SSRIs) by their doctors to treat depression. Many mothers do not know that taking antidepressants during pregnancy can lead [...]
February 5, 2015

Keeping Up with Dangerous Drug Recalls

Keeping Up with Dangerous Drug RecallsOn Behalf of Brayton Purcell LLP | Feb 5, 2015 | Dangerous Medical Drugs | Prescription and over-the-counter drugs are constantly being recalled. If you have been prescribed a “cocktail” of medications by your doctor, keeping track of which drugs have been found to be dangerous might be a good [...]
January 19, 2015

Drugs that Can Cause Birth Defects

When watching prescription drug commercials on television, have you ever heard the narrator quickly zipping through a list of dangerous side effects? In some cases, for pregnant women, these side effects can include birth defects. Our attorneys are currently reviewing the cases of those who have given birth to babies with birth defects after taking [...]
October 23, 2014

Study Calls for Stricter FDA Enforcement on Supplements

Study Calls for Stricter FDA Enforcement on Supplementsby Brayton Purcell LLP | Oct 23, 2014 | Dangerous Medical Drugs | While the FDA is busy building felony cases against bad drug companies, those very companies often continue to sell their tainted drug to the public. The most recent study, published in JAMA, the Journal of [...]
October 15, 2014

Low Testosterone Drugs May Increase Risk of Serious Health Problems

Low Testosterone Drugs May Increase Risk of Serious Health Problemsby Brayton Purcell LLP | Oct 15, 2014 | Dangerous Medical Drugs | Low testosterone drugs may cause serious health problems in some men. Men who take prescription medication to raise their testosterone levels also may be raising their risk of other serious health problems. Research [...]
June 2, 2014

Pharmaceutical Company Settles Pradaxa Claims for $650 Million

You might not have guessed it, but medical drug injuries are a big problem in the United States. There are many prescriptions approved by the FDA and available for patient use, but some are not the miracle-workers that advertisements claim them to be.Recently, Boehring Ingelheim resolved more than 4,000 claims involving their drug Pradaxa, an [...]
November 19, 2013

Partner Post: Risperdal Anti-Psychotic Drug Settlement

by Brayton Purcell LLP | Nov 19, 2013 | Dangerous Medical Drugs | $2.2 Billion Risperdal Anti-Psychotic Drug Settlement Written by James P. Nevin  Janssen, part of the well-known Johnson & Johnson company, pled guilty to misbranding its anti-psychotic medication Risperdal in a $2.2 billion dollar settlement. The company entered a guilty plea to one misdemeanor [...]
April 8, 2013

Recall on GranuFlo and Naturalyte

On March 29, 2012, the Federal Drug Administration (FDA) recalled Granuflo, a powder acid concentrate, and Naturalyte, a liquid acid concentrate. Both products had been linked to cardiopulmonary arrests in dialysis patients. and Naturalyte were manufactured and distributed between January 2008 through June 2012 to Fresenius Medical Care North America and other dialysis centers. After [...]